title: [Anticoagulation for plasmapheresis].
authors.affiliation: Department of Clinical Engineering, Showa University Fujigaoka Hospital.
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Amemiya
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Sekihara
authors.forename: Tutomu
authors.initials: T
authors.lastname: Kobayashi
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Koiwa
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Niikura
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D001550:Benzamidines; D002951:Citrates / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D006146:Guanidines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D008991:Monitoring, Physiologic; D010956:Plasmapheresis / Q000379:methods*; D000077559:Sodium Citrate; D014914:Whole Blood Coagulation Time
chemical_list: D000925:Anticoagulants; D001550:Benzamidines; D002951:Citrates; D006146:Guanidines; D006495:Heparin, Low-Molecular-Weight; D000077559:Sodium Citrate; D006493:Heparin; C032855:nafamostat